{"name":"Hyuk moon Kim","slug":"hyuk-moon-kim","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"early leukostim","genericName":"early leukostim","slug":"early-leukostim","indication":"Reducing the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"late leukostim","genericName":"late leukostim","slug":"late-leukostim","indication":"Treatment of severe chronic neutropenia","status":"marketed"}]}],"pipeline":[{"name":"early leukostim","genericName":"early leukostim","slug":"early-leukostim","phase":"marketed","mechanism":"Early leukostim stimulates the production of white blood cells.","indications":["Reducing the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy"],"catalyst":""},{"name":"late leukostim","genericName":"late leukostim","slug":"late-leukostim","phase":"marketed","mechanism":"Late leukostim stimulates the proliferation of hematopoietic progenitor cells.","indications":["Treatment of severe chronic neutropenia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE9fdlREYURRemh1ZW1LZFRsakU4OElRLTFCX3B2aWxmdVNRLUhMLXdFNU9ZbktKWFh5Nl9lbE5zbkJXVWRGd0J1aTNRZlUyRUhhX3hORUt3M2pjZzlUMW5iY3E5NA?oc=5","date":"2025-12-05","type":"pipeline","source":"매일경제","summary":"‘Dear X’: Kim Yoo-jung’s Dazzling Fall... A Shocking Ending That Lingers - 매일경제","headline":"‘Dear X’: Kim Yoo-jung’s Dazzling Fall... A Shocking Ending That Lingers - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFA0WXdzeDZ3QkRVazRSQXpHM3RDUlpkYjVUN3VlbkFEak9va3JkaFlyM2Ftbkd4SnlmTC1vVVVpbzhIdi16ZVZ1Vk91N1BJZ1g2YWg1Wnl3?oc=5","date":"2025-12-04","type":"pipeline","source":"매일경제","summary":"[Living Room OTT] ‘Dear X’ Final Episode Released Today... Kim Yoo-jung Spotted Running in a Dress - 매일경제","headline":"[Living Room OTT] ‘Dear X’ Final Episode Released Today... Kim Yoo-jung Spotted Running in a Dress - 매일경제","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}